268 related articles for article (PubMed ID: 23060704)
1. Lasers for treatment of melasma and post-inflammatory hyperpigmentation.
Arora P; Sarkar R; Garg VK; Arya L
J Cutan Aesthet Surg; 2012 Apr; 5(2):93-103. PubMed ID: 23060704
[TBL] [Abstract][Full Text] [Related]
2. The Asian dermatologic patient: review of common pigmentary disorders and cutaneous diseases.
Ho SG; Chan HH
Am J Clin Dermatol; 2009; 10(3):153-68. PubMed ID: 19354330
[TBL] [Abstract][Full Text] [Related]
3. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
4. Optimizing Q-switched lasers for melasma and acquired dermal melanoses.
Aurangabadkar SJ
Indian J Dermatol Venereol Leprol; 2019; 85(1):10-17. PubMed ID: 30027914
[TBL] [Abstract][Full Text] [Related]
5. Using reflectance confocal microscopy to observe in vivo melanolysis after treatment with the picosecond alexandrite laser and Q-switched Nd:YAG laser in melasma.
Jo DJ; Kang IH; Baek JH; Gwak MJ; Lee SJ; Shin MK
Lasers Surg Med; 2019 Jul; 51(5):423-429. PubMed ID: 30351494
[TBL] [Abstract][Full Text] [Related]
6. A review of laser and light therapy in melasma.
Trivedi MK; Yang FC; Cho BK
Int J Womens Dermatol; 2017 Mar; 3(1):11-20. PubMed ID: 28492049
[TBL] [Abstract][Full Text] [Related]
7. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Melasma and Post-Inflammatory Hyperpigmentation by a Picosecond 755-nm Alexandrite Laser in Asian Patients.
Lee YJ; Shin HJ; Noh TK; Choi KH; Chang SE
Ann Dermatol; 2017 Dec; 29(6):779-781. PubMed ID: 29200769
[TBL] [Abstract][Full Text] [Related]
9. Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion.
Sofen B; Prado G; Emer J
Skin Therapy Lett; 2016 Jan; 21(1):1-7. PubMed ID: 27224897
[TBL] [Abstract][Full Text] [Related]
10. Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: two case reports.
Polnikorn N
J Cosmet Laser Ther; 2008 Sep; 10(3):167-73. PubMed ID: 18788035
[TBL] [Abstract][Full Text] [Related]
11. Laser Toning in Melasma.
Shah SD; Aurangabadkar SJ
J Cutan Aesthet Surg; 2019; 12(2):76-84. PubMed ID: 31413475
[TBL] [Abstract][Full Text] [Related]
12. Topical Treatments for Melasma and Post-inflammatory Hyperpigmentation.
Sadick N; Pannu S; Abidi Z; Arruda S
J Drugs Dermatol; 2023 Nov; 22(11):1118-1123. PubMed ID: 37943277
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of laser-related therapy for melasma: A systematic review and network meta-analysis.
Ma W; Gao Q; Liu J; Zhong X; Xu T; Wu Q; Cheng Z; Luo N; Hao P
J Cosmet Dermatol; 2023 Nov; 22(11):2910-2924. PubMed ID: 37737021
[TBL] [Abstract][Full Text] [Related]
14. A Prospective Randomized Controlled Study of Oral Tranexamic Acid for the Prevention of Postinflammatory Hyperpigmentation After Q-Switched 532-nm Nd:YAG Laser for Solar Lentigines.
Rutnin S; Pruettivorawongse D; Thadanipon K; Vachiramon V
Lasers Surg Med; 2019 Dec; 51(10):850-858. PubMed ID: 31302943
[TBL] [Abstract][Full Text] [Related]
15. Advancements in Laser Therapies for Dermal Hyperpigmentation in Skin of Color: A Comprehensive Literature Review and Experience of Sequential Laser Treatments in a Cohort of 122 Indian Patients.
Garg S; Vashisht KR; Garg D; Oberoi B; Sharma G
J Clin Med; 2024 Apr; 13(7):. PubMed ID: 38610881
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomized comparative study on 60 Indian patients of melasma, comparing pixel Q-switched NdYAG (1064 nm), super skin rejuvenation (540 nm) and ablative pixel erbium YAG (2940 nm) lasers, with a review of the literature.
Garg S; Vashisht KR; Makadia S
J Cosmet Laser Ther; 2019 Aug; 21(5):297-307. PubMed ID: 31010346
[No Abstract] [Full Text] [Related]
17. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review.
Levin MK; Ng E; Bae YS; Brauer JA; Geronemus RG
Lasers Surg Med; 2016 Feb; 48(2):181-7. PubMed ID: 26922302
[TBL] [Abstract][Full Text] [Related]
19. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
Alsaad SM; Ross EV; Mishra V; Miller L
Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
[TBL] [Abstract][Full Text] [Related]
20. Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation.
Ko D; Wang RF; Ozog D; Lim HW; Mohammad TF
J Am Acad Dermatol; 2023 Feb; 88(2):291-320. PubMed ID: 35158001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
